Interpreting Results from Clinical Trials: Understanding Minimal Clinically Important Differences in COPD Outcomes
Barry J. Make, Richard Casaburi, Nancy Kline Leidy
Abstract
Open-access reader
Barry J. Make, Richard Casaburi, Nancy Kline Leidy
Abstract
Open-access reader
This issue of the COPD: Journal of Chronic Obstructive Pulmonary Disease presents the papers from the “Workshop on Minimal Clinically Important Differences in COPD” held in Bal Harbour, Florida, on January 11–13, 2004. The goals of this meeting were to: discuss the significance of and methodology for determining minimal clinically important differences (MCID) in health outcomes of importance in chronic obstructive pulmonary disease (COPD); review the current knowledge about MCID in outcomes of importance, including dyspnea, quality of life, exercise performance, and pulmonary function, in the management of patients with COPD; apply methodologies to determine MCID using existing data for outcomes of importance in COPD; and develop recommendations for further studies to determine MCID in health outcomes of importance in COPD.
OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This issue of the COPD: Journal of Chronic Obstructive Pulmonary Disease presents the papers from the “Workshop on Minimal Clinically Important Differences in COPD” held in Bal Harbour, Florida, on January 11–13, 2004. The goals of this meeting were to: discuss the significance of and methodology for determining minimal clinically important differences (MCID) in health outcomes of importance in chronic obstructive pulmonary disease (COPD); review the current knowledge about MCID in outcomes of importance, including dyspnea, quality of life, exercise performance, and pulmonary function, in the management of patients with COPD; apply methodologies to determine MCID using existing data for outcomes of importance in COPD; and develop recommendations for further studies to determine MCID in health outcomes of importance in COPD.
Key concepts: Minimal clinically important difference, COPD, Medicine, Pulmonary disease, Physical therapy, Quality of life (healthcare), Pulmonary function testing, Clinical trial